Comparing the effects of dietary selenium and mannan oligosaccharide supplementation on the growth, immune function, and antioxidant enzyme activity in the cultured marron Cherax cainii (Austin, 2002)

This study was conducted to compare the effects of dietary supplementation of selenium (Se, both inorganic and organic) and mannan oligosaccharide (MOS) on the growth, immune function, and antioxidant enzyme activities in the haemolymph of the marron Cherax cainii (Austin, 2002); 0.4 mg kg-1 of sodium selenate, 0.2 g kg-1 Sel-Plex®, or 0.4 % Bio-MOS® was added to the basal diet as sources of inorganic selenium (IS), organic selenium (OS), and MOS, respectively. After 90 days, marron fed all 3 supplemented test diets had significantly higher final weight, specific growth rate (SGR), survival, total haemocyte count (THC), percentage of hyaline cells, glutathione-S-transferase (GST), and glutathione peroxidase (GPx) activities than marron fed without any supplements. The marron fed OS showed significantly higher THC and percentage of hyaline cells than those fed IS and MOS. Marron fed MOS showed the highest final weight, SGR, and percentage of granular cells; however, there was no significant difference in the neutral red time retention between marron fed IS and OS, whereas marron fed OS resulted in the highest GPx activity and total Se levels in the haemolymph but the lowest lipid peroxidase activity; therefore, it is suggested that dietary supplementation with any source of Se and MOS is beneficial to improving growth, survival, and antioxidant activity

Acorn consumption improves the immune response of the dung beetle Thorectes lusitanicus

Thorectes lusitanicus, a typically coprophagous species is also actively attracted to oak acorns, consuming, burying them, and conferring ecophysiological and reproductive advantages to both the beetle and the tree. In this study, we explored the possible relation between diet shift and the health status of T. lusitanicus using a generalist entomopathogenic fungus (Metarhizium anisopliae) as a natural pathogen. To measure the health condition and immune response of beetles, we analysed the protein content in the haemolymph, prophenoloxidase (proPO) content, phenoloxidase (PO) activity and mortality of beetles with diets based on either acorns or cow dung. Protein content, proPO levels and PO levels in the haemolymph of T. lusitanicus were found to be dependent on the type of diet. Furthermore, the beetles fed with acorns developed a more effective proPO-PO system than the beetles fed with cow dung. Furthermore, a significant decrease in mortality was observed when infected individuals were submitted to an acorn-based diet. In addition to enhancing an understanding of the relevance of dietary change to the evolutionary biology of dung beetles, these results provide a more general understanding of the ecophysiological implications of differential dietary selection in the context of fitness.Financial support was provided by the Projects CGL2008/03878/BOS and CGL2011-25544 of the Secretaría de Estado de Investigación-Ministerio de Educación, Ciencia e Innovación (http://www.mecd.gob.es/portada-mecd/) and OAPN 762/2012, Ministerio de Agricultura, Alimentación y Medio Ambiente (http://www.magrama.gob.es/es/)

Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review.

This is the final version. Available from Nature Research via the DOI in this record. Data availability: All studies reviewed were identified and can be accessed via publicly available databases (PubMed and Embase). Source data can be found in Supplementary Data 3. A full list of included studies is available in Supplementary Data 6. Article review data supporting the findings of this study are available upon reasonable request from the corresponding author.BACKGROUND: Islet autoantibodies form the foundation for type 1 diabetes (T1D) diagnosis and staging, but heterogeneity exists in T1D development and presentation. We hypothesized that autoantibodies can identify heterogeneity before, at, and after T1D diagnosis, and in response to disease-modifying therapies. METHODS: We systematically reviewed PubMed and EMBASE databases (6/14/2022) assessing 10 years of original research examining relationships between autoantibodies and heterogeneity before, at, after diagnosis, and in response to disease-modifying therapies in individuals at-risk or within 1 year of T1D diagnosis. A critical appraisal checklist tool for cohort studies was modified and used for risk of bias assessment. RESULTS: Here we show that 152 studies that met extraction criteria most commonly characterized heterogeneity before diagnosis (91/152). Autoantibody type/target was most frequently examined, followed by autoantibody number. Recurring themes included correlations of autoantibody number, type, and titers with progression, differing phenotypes based on order of autoantibody seroconversion, and interactions with age and genetics. Only 44% specifically described autoantibody assay standardization program participation. CONCLUSIONS: Current evidence most strongly supports the application of autoantibody features to more precisely define T1D before diagnosis. Our findings support continued use of pre-clinical staging paradigms based on autoantibody number and suggest that additional autoantibody features, particularly in relation to age and genetic risk, could offer more precise stratification. To improve reproducibility and applicability of autoantibody-based precision medicine in T1D, we propose a methods checklist for islet autoantibody-based manuscripts which includes use of precision medicine MeSH terms and participation in autoantibody standardization workshops.DiabDocs K12 programLeona M. & Harry B. Helmsley Charitable TrustNIH NIDDKDiabetes UK Harry Keen FellowshipNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of HealthNational Institute of HealthNational Institute of Healt